Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06320626
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-02-28
Brief Title:
Pharmacokinetic-guided Dosing of Emicizumab
Sponsor:
Kathelijn Fischer
Organization:
UMC Utrecht
Organization Data
Organization:
UMC Utrecht
Class:
OTHER
Study ID:
22-571
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kathelijn Fischer
Lead Sponsor Class:
OTHER
Responsible Party:
Kathelijn Fischer
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
UMC Utrecht
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dutch Society of Haemophilia Patients | UNKNOWN |
| Erasmus Medical Center | OTHER |
| Amsterdam University Medical Center | OTHER |
| Leiden University Medical Center | OTHER |
| Radboud University Medical Center | OTHER |
| Maastricht University Medical Center | OTHER |
| University Medical Center Groningen | OTHER |
| HagaZiekenhuis | OTHER |